“Global Gene Corp Appoints Harvard Faculty, Dr Jonathan Picker as new CEO”

Global Gene Corp is delighted to announce that our Board of Directors have appointed Dr Jonathan Picker to take on the role of CEO of the Company.
Jonathan was the lead Co-founder of Global Gene Corp and has been responsible for the company’s scientific mission and the product delivery infrastructure. Jonathan was previously at the Boston Children’s Hospital where he co-founded and co-directed the pharmacogenomics clinic. He holds a PhD in molecular biology and a fellowship at #Harvard in both Genetics and Child & Adolescent Psychiatry. Jonathan is the recipient of the Warren Dupont and Boston Children’s Developmental Medicine Research Fellowship awards and was the first recipient of the Sidney R. Baer Jr. Prize for Mental health Research. “I look forward to leading our endeavor to bring the opportunities of the Human Genome project to Asia. This will bring discovery, research, and medical innovation to the region. A promise to transform health and wellness for all.” Jonathan will be based in Boston, Massachusetts.

The Company is also very pleased to announce that fellow Co-founder, Kushagra Sharma, has been appointed to the Board of Directors and will lead the business function. “As we enter a robust growth phase, I’m very confident that our team will provide the strong scientific leadership, and governance structure that is required to achieve all our goals.” Prior to founding Global Gene Corp, Kushagra was a senior leader in the technology and telecom sector.
Sumit Jamuar and Saumya Jamuar have resigned from all roles at Global Gene Corp. The Company thanks them for their contribution and wishes them well in their future endeavors.

About Global Gene Corp: Singapore, Boston and India based Global Gene Corp is an innovative genomic data platform, paving the way for delivery of precision healthcare. Global Gene Corp investigates scientifically underrepresented populations in Asia and harnesses characterized genetic variant and copy number analytics to the individual, systematically phenotyped; epidemiologically, clinically and for defined biomarkers. This allows correlations that, when undertaken at the population level central to the Global Gene Corp process, powers the identification of biologically relevant pathways. These are core to novel drug and biotechnology advances. By focusing this approach on diverse under-represented populations that provide Global Gene Corp’s Asian biobank, our genomic centric data platform completes the missing link for researchers, pharmaceutical companies and healthcare service providers.

×
Dr. Jonathan Picker Chief Executive Office

Dr. Jonathan Picker is the Chief Executive Officer of Anuva. He is an affiliate faculty member and clinical geneticist at Boston's Children's Hospital, Harvard Medical School.

With 25 years of experience in Pediatrics and Genetics, Dr. Picker specializes in the interface of clinical care and applied genetic and genomic research. Dr. Picker's research spans diagnostic tools in genetics to descriptive analysis of rare disorders to molecular neuroscience. He was the co-founder and Director of the first Pediatric Pharmacogenomic clinic in the USA; as well as Director of the Harvard Medical School Advanced Human Genetics Training Program Course.

Dr. Picker is the recipient of various prestigious awards, including the first Sidney R. Baer Jr. Prize for Mental health Research. He has authored numerous research papers involving informative cases, molecular biology, behavioral neuroscience, applied clinical genetic guidelines as well as invited reviews and chapters.

Dr. Picker holds a bachelor's degree of Medical Biology in Genetics, and an MBChB in Medicine from Aberdeen University, UK. He also holds an MS in Genetics and Biochemistry and a PhD in Molecular Biology from Newcastle University, UK.

×
Kushagra SharmaPresident & Board Member

Kushagra Sharma is the President and a Board Member at Anuva. A seasoned business leader with a career spanning entrepreneurship as well as general management, Kushagra has deep expertise in developing and executing business plans in start-ups as well as large corporations. He is responsible for the revenue growth of the business, strategic planning, and partnerships at Anuva.

Before joining Anuva, he was responsible for the strategy and project execution in launching 4G digital services for Reliance Jio in India. Kushagra has previously served in leadership roles in companies like British Telecom, MTS Sistema Shyam, Grail Research and Evalueserve.

He holds a bachelor's degree from Indian Institute of Technology, Delhi and an MBA from INSEAD, Fontainebleau.

×
Dr. Asmi ShahVice President of Data and Technology

Dr. Asmi Shah is the Vice President of Data and Technology at Anuva. She joined Anuva in its very initial years and has contributed significantly in shaping its products end to end along with other R&D platforms. She brings her data science expertise in dealing with big data, managing and standardizing multidisciplinary large scale biological datasets in the field of drug discovery through genomics and phenomics.

Before joining Anuva, she contributed to the research of drug discovery done with the use of high content/throughput screening on various zebrafish assays at University of Heidelberg in Germany and at Harvard Medical School, USA. She has also taken up various technical roles in product management and software R&D with different corporate industries such as Intel, Rambus and Inform Technologies in the USA and with data analytics startups in India.

Dr Shah holds a bachelor’s degree from Saurashtra University, India, an MS from San Jose State University, USA and has pursued her PhD from University of Heidelberg, Germany under a Marie Curie fellowship.

×
Dr. Nick England Vice President of Bioinformatics

Dr Nick England is the Vice President of Bioinformatics at Anuva. He brings with him over 10 years of commercial bioinformatics experience. He is responsible for the development of bespoke bioinformatics software and pipelines to maximize biological insight from our data.

Before joining Anuva, he worked at Kymab where he developed the bioinformatics used in IntelliSelect for processing and visualizing antibodies from humanized mice, as well as implementing continuous integration and shifting computation to the cloud. This successful informatics platform is now also used by other companies such as LifeArc and Petmedix. He has previously worked on cheminformatics projects with Unilever and Novartis.

Dr England holds an MSci degree in Natural Sciences as well as a PhD in cheminformatics from the University of Cambridge.